Difference between revisions of "Part:BBa K2686002:Design"
(→Source) |
(→Design Notes) |
||
(7 intermediate revisions by the same user not shown) | |||
Line 7: | Line 7: | ||
===Design Notes=== | ===Design Notes=== | ||
− | The HexaHistidine sequence was | + | The HexaHistidine sequence (GGGGGGHHHHHHGGGGG) was introduced in between amino acids 43/44 in <bbpart>BBa_K2686001</bbpart> which is shifted by one amino acid downstream compared to the location in <bbpart>BBa_K192000<bbpart> where it would be in between amino acids 42/43 (Moon et al., 2014). |
− | + | ||
− | + | ||
===Source=== | ===Source=== | ||
− | Derived from [[ | + | Derived from [[parts.igem.org/Part:BBa_K2686001|BBa_K2686001]]. |
===References=== | ===References=== | ||
+ | Moon, H., Lee, J., Min, J. and Kang, S. (2014). Developing Genetically Engineered Encapsulin Protein Cage Nanoparticles as a Targeted Delivery Nanoplatform. Biomacromolecules, 15(10), pp.3794-3801. |
Latest revision as of 23:11, 17 October 2018
Encapsulin protein with HexaHistidine insert
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21INCOMPATIBLE WITH RFC[21]Illegal BglII site found at 77
Illegal BglII site found at 492 - 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000INCOMPATIBLE WITH RFC[1000]Illegal SapI.rc site found at 426
Illegal SapI.rc site found at 457
Design Notes
The HexaHistidine sequence (GGGGGGHHHHHHGGGGG) was introduced in between amino acids 43/44 in BBa_K2686001 which is shifted by one amino acid downstream compared to the location in BBa_K192000